Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)

被引：2

作者：

Gatzemeier, Ulrich

Taylor, Paul

von Pawel, Joachim

Castagneto, Bruno

Dark, Graham

Marangolo, Maurizio

Van Klaveren, Rob J.

Van Meerbeeck, Jan

Adachi, Jan

Blatter, Johannes

机构：

[1] Hosp Grosshansdorf, Grosshansdorf, Germany

[2] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England

[3] Asklepios Fachkliniken Munchen, Gauting, Germany

[4] San Giacomo Hosp, Novi Ligure, Italy

[5] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England

[6] City Hosp, Ravenna, Italy

[7] Erasmus MC, Rotterdam, Netherlands

[8] Univ Hosp Ghent, Ghent, Belgium

[9] Eli Lilly & Co, Indianapolis, IN 46285 USA

[10] Eli Lilly & Co, Bad Homburg, Germany

来源：

关键词：

D O I：

10.1097/01.JTO.0000283218.40896.16

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S372 / S373

页数：2